PT  - JOURNAL ARTICLE
AU  - Haouchine, Nazim
AU  - Hackney, David B.
AU  - Pieper, Steve D.
AU  - Wells, William M.
AU  - Sanhinova, Malika
AU  - Balboni, Tracy A.
AU  - Spektor, Alexander
AU  - Huynh, Mai A.
AU  - Kozono, David E.
AU  - Doyle, Patrick
AU  - Alkalay, Ron N.
TI  - An Open Annotated Dataset and Baseline Machine Learning Model for Segmentation of Vertebrae with Metastatic Bone Lesions from CT
AID  - 10.1101/2024.10.14.24314447
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.10.14.24314447
4099  - http://medrxiv.org/content/early/2024/11/12/2024.10.14.24314447.short
4100  - http://medrxiv.org/content/early/2024/11/12/2024.10.14.24314447.full
AB  - Automatic analysis of pathologic vertebrae from computed tomography (CT) scans could significantly improve the diagnostic management of patients with metastatic spine disease. We provide the first publicly available annotated imaging dataset of cancerous CT spines to help develop artificial intelligence frameworks for automatic vertebrae segmentation and classification. This collection contains a dataset of 55 CT scans collected on patients with various types of primary cancers at two different institutions. In addition to raw images, data include manual segmentations and contours, vertebral level labeling, vertebral lesion-type classifications, and patient demographic details. Our automated segmentation model uses nnU-Net, a freely available open-source framework for deep learning in healthcare imaging, and is made publicly available. This data will facilitate the development and validation of models for predicting the mechanical response to loading and the resulting risk of fractures and spinal deformity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the NIAMS and the NIBIB of the National Institutes of Health under award numbers R01AR075964, 3R01AR075964-03S1, and K25EB035166. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB or Beth Israel Deaconess Medical Center, Brigham and Women's Hospital and Dana Farber Cancer Institute ​​gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe images and associated files are publicly available on The Cancer Imaging Archive.https://doi.org/10.7937/kh36-ds04